Nifty
Sensex
:
:
12987.00
44259.74
128.60 (1.00%)
431.64 (0.98%)

Pharmaceuticals & Drugs - Global

Rating :
57/99  (View)

BSE: 530549 | NSE: SHILPAMED

464.70
2.55 (0.55%)
26-Nov-2020 | 3:59PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  466.00
  •  475.00
  •  460.00
  •  462.15
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  488312
  •  2269.19
  •  695.00
  •  233.15

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 3,764.50
  • 17.01
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 4,109.82
  • 0.24%
  • 2.58

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 53.25%
  • 6.40%
  • 17.00%
  • FII
  • DII
  • Others
  • 15.9%
  • 2.83%
  • 4.62%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 12.08
  • 4.85
  • 4.80

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 11.76
  • 6.04
  • 7.24

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 12.23
  • 7.34
  • 11.65

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 26.89
  • 31.69
  • 25.26

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 4.06
  • 4.09
  • 2.86

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 19.93
  • 21.76
  • 17.35

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Net Sales
279
290
-4%
223
161
38%
220
200
10%
237
173
37%
Expenses
210
222
-5%
157
132
19%
174
162
8%
163
147
11%
EBITDA
69
68
1%
66
29
128%
46
37
22%
74
26
182%
EBIDTM
25%
23%
30%
18%
14%
19%
31%
15%
Other Income
9
6
58%
5
2
177%
9
3
188%
3
3
4%
Interest
4
1
382%
4
1
174%
1
1
-28%
1
1
19%
Depreciation
13
11
19%
12
11
16%
12
11
10%
11
11
-2%
PBT
61
62
-2%
116
19
520%
42
28
48%
65
11
476%
Tax
16
11
43%
29
4
620%
8
6
35%
11
0
-
PAT
45
51
-12%
87
15
493%
34
22
51%
54
12
364%
PATM
16%
18%
39%
9%
7%
11%
23%
7%
EPS
5.55
6.28
-12%
10.63
1.79
494%
4.17
2.76
51%
6.65
1.44
362%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Net Sales
959
908
733
789
779
716
614
571
371
318
290
Net Sales Growth
16%
24%
-7%
1%
9%
17%
7%
54%
17%
10%
 
Cost Of Goods Sold
4,876
278
257
356
372
366
323
313
214
183
163
Gross Profit
-3,917
630
476
433
407
350
291
258
157
135
127
GP Margin
-409%
69%
65%
55%
52%
49%
47%
45%
42%
42%
44%
Total Expenditure
705
693
579
638
618
556
487
455
302
257
220
Power & Fuel Cost
-
39
34
29
26
22
19
17
11
9
7
% Of Sales
-
4%
5%
4%
3%
3%
3%
3%
3%
3%
2%
Employee Cost
-
197
176
149
128
90
82
68
43
34
28
% Of Sales
-
22%
24%
19%
16%
13%
13%
12%
11%
11%
10%
Manufacturing Exp.
-
79
61
60
53
45
37
27
17
13
8
% Of Sales
-
9%
8%
8%
7%
6%
6%
5%
5%
4%
3%
General & Admin Exp.
-
70
27
22
17
14
11
10
10
8
6
% Of Sales
-
8%
4%
3%
2%
2%
2%
2%
3%
2%
2%
Selling & Distn. Exp.
-
10
7
6
5
7
6
7
4
3
5
% Of Sales
-
1%
1%
1%
1%
1%
1%
1%
1%
1%
2%
Miscellaneous Exp.
-
20
17
15
17
12
9
13
4
7
5
% Of Sales
-
2%
2%
2%
2%
2%
2%
2%
1%
2%
1%
EBITDA
254
215
154
151
162
160
126
116
70
61
71
EBITDA Margin
26%
24%
21%
19%
21%
22%
21%
20%
19%
19%
24%
Other Income
27
22
16
33
29
11
7
9
5
8
9
Interest
10
5
4
3
3
4
4
4
2
2
3
Depreciation
48
44
42
37
31
23
21
23
15
14
13
PBT
283
188
124
144
157
144
108
98
57
53
64
Tax
63
33
26
34
42
36
35
20
10
12
15
Tax Rate
22%
18%
18%
24%
28%
25%
33%
21%
17%
23%
23%
PAT
220
156
120
112
114
110
74
76
47
41
49
PAT before Minority Interest
221
155
118
110
111
106
73
75
47
41
49
Minority Interest
1
2
3
2
3
4
1
1
0
0
0
PAT Margin
23%
17%
16%
14%
15%
15%
12%
13%
13%
13%
17%
PAT Growth
120%
30%
7%
-1%
4%
49%
-3%
60%
15%
-16%
 
EPS
27.01
19.20
14.76
13.80
13.95
13.48
9.04
9.28
5.81
5.06
6.06

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
1,329
1,198
1,085
987
639
547
396
320
276
225
Share Capital
8
8
8
8
8
8
7
5
5
5
Total Reserves
1,321
1,189
1,077
979
632
539
389
316
271
214
Non-Current Liabilities
257
167
153
251
67
154
105
99
31
32
Secured Loans
164
80
67
141
0
71
37
70
5
11
Unsecured Loans
1
1
1
1
0
31
30
0
0
0
Long Term Provisions
26
22
20
17
14
12
10
7
6
6
Current Liabilities
408
253
266
237
222
189
167
124
121
80
Trade Payables
89
81
104
112
106
76
93
51
57
28
Other Current Liabilities
142
82
60
28
36
49
38
23
20
17
Short Term Borrowings
165
87
98
92
74
58
30
45
41
33
Short Term Provisions
11
5
4
5
5
6
5
4
3
3
Total Liabilities
1,986
1,610
1,499
1,472
931
905
678
551
433
338
Net Block
650
558
534
492
393
316
294
181
167
146
Gross Block
986
853
793
705
582
476
448
301
271
233
Accumulated Depreciation
336
295
259
213
189
160
154
120
105
87
Non Current Assets
1,365
1,065
827
742
577
577
444
339
245
160
Capital Work in Progress
666
429
210
141
92
222
111
129
58
3
Non Current Investment
10
2
21
28
34
0
0
0
0
4
Long Term Loans & Adv.
32
49
37
77
52
39
38
29
20
7
Other Non Current Assets
6
27
25
5
5
0
0
0
0
0
Current Assets
621
545
672
730
354
328
234
212
188
178
Current Investments
0
0
120
225
60
65
10
50
68
0
Inventories
226
188
189
190
134
131
123
74
67
43
Sundry Debtors
244
204
220
171
125
81
68
42
41
40
Cash & Bank
45
95
74
100
11
18
9
17
2
87
Other Current Assets
106
45
26
22
24
32
23
29
10
8
Short Term Loans & Adv.
29
14
44
22
9
5
3
3
3
2
Net Current Assets
213
292
406
493
132
139
67
88
67
98
Total Assets
1,986
1,610
1,499
1,472
931
905
678
551
433
338

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
124
147
45
37
129
69
70
44
57
41
PBT
188
144
137
146
140
108
95
57
54
64
Adjustment
41
20
19
17
21
26
20
12
10
10
Changes in Working Capital
-64
19
-70
-93
-3
-40
-23
-14
1
-21
Cash after chg. in Working capital
166
183
86
71
158
94
92
55
64
54
Interest Paid
0
0
0
0
0
0
0
0
0
0
Tax Paid
-42
-36
-41
-34
-30
-25
-22
-11
-8
-13
Other Direct Exp. Paid
0
0
0
0
0
0
0
0
0
0
Extra & Other Items
0
0
0
0
0
0
0
0
0
0
Cash From Investing Activity
-289
-196
-9
-262
-109
-195
-49
-95
-152
8
Net Fixed Assets
-4
-257
-137
-172
-92
-78
-61
-84
-79
-5
Net Investments
-4
142
96
-173
-14
-64
12
14
-73
-24
Others
-280
-81
32
83
-3
-52
0
-26
0
37
Cash from Financing Activity
176
10
-61
313
-20
135
-28
66
10
36
Net Cash Inflow / Outflow
10
-39
-25
88
0
9
-7
15
-86
85
Opening Cash & Equivalents
34
74
100
7
4
9
17
2
88
3
Closing Cash & Equivalent
45
34
74
100
6
18
9
17
2
87

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
163
147
133
123
83
71
108
44
75
61
ROA
9%
8%
7%
9%
12%
9%
12%
10%
11%
17%
ROE
12%
10%
11%
14%
18%
15%
21%
16%
17%
31%
ROCE
12%
11%
12%
16%
20%
18%
20%
15%
18%
29%
Fixed Asset Turnover
0.99
0.89
1.06
1.22
1.36
1.34
1.54
1.32
1.28
1.30
Receivable days
90
106
90
69
52
44
35
40
45
46
Inventory Days
83
94
87
75
67
75
62
68
62
58
Payable days
47
58
62
61
60
63
57
64
59
55
Cash Conversion Cycle
126
141
116
84
59
56
40
44
49
49
Total Debt/Equity
0.29
0.16
0.18
0.24
0.14
0.34
0.30
0.41
0.22
0.26
Interest Cover
42
40
55
50
37
28
28
26
24
25

News Update


  • Shilpa Medicare gets warning letter from USFDA for Jadcherla facility
    12th Oct 2020, 13:28 PM

    The warning letter will have minimum impact of disruption of supplies and the existing revenues from operations of this facility

    Read More
  • Shilpa Medicare gets nod to establish whole owned subsidiary in Malaysia
    18th Sep 2020, 14:40 PM

    The Board of Directors of the company at its meeting held on September 18, 2020 approved the same

    Read More
  • Shilpa Medicare forays into OTC segment
    25th Aug 2020, 09:29 AM

    The company has forayed into OTC segment with the launch of ready-to-drink green tea films

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.